| Revenues | | 1,103.00 | 1,043.00 | 1,152.00 | 1,121.00 |
| | 133.00 | 130.00 | - | - |
| Selling, General, and Administrative | | 133.00 | 130.00 | - | - |
| Research and Development | | 20.00 | 20.00 | - | - |
| Costs And Expenses | | 947.00 | 959.00 | 996.00 | 1,011.00 |
| Operating Income/Loss | | 156.00 | 84.00 | 156.00 | 110.00 |
| Nonoperating Income/Loss | | -4.00 | 12.00 | -13.00 | -9.00 |
| Income/Loss From Equity Method Investments | -1.00 | - | - | - | -1.00 |
| Income/Loss From Continuing Operations Before Tax | | 90.00 | 33.00 | 77.00 | 33.00 |
| Income Tax Expense/Benefit, Deferred | | -3.00 | 1.00 | -17.00 | 13.00 |
| Income Tax Expense/Benefit | | 25.00 | 11.00 | -8.00 | 7.00 |
| | 65.00 | 22.00 | 85.00 | 26.00 |
| Attributable To Parent | | 65.00 | 22.00 | 83.00 | 26.00 |
| Attributable To Noncontrolling Interest | - | - | - | 2.00 | - |
| Basic Average Shares | | 73.80 | 73.60 | 73.70 | 73.70 |
| Diluted Average Shares | | 75.80 | 75.60 | 76.30 | 76.00 |
| Basic Earnings Per Share | | 0.88 | 0.30 | 1.13 | 0.35 |
| Diluted Earnings Per Share | | 0.86 | 0.29 | 1.09 | 0.34 |
